4
Changes in Ownership
MAIA Biotechnology, Inc. Filed Acc 0001127602-25-004350
Options or other derivatives
- Chief Scientific Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gryaznov Sergei · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-10 | Grant or award : show line 1 in the form Stock Options | +200,000 | 200,000 | D |
Loading xslF345X05/form4.xml…